Product Description
lower price 98%(HPLC) White or slightly yellow crystalline powder Olanzapine 132539-06-1
AI Product Description
*The following content is generated by AI and is for reference only.
Olanzapine, identified by the CAS number 132539-06-1, is a potent atypical antipsychotic agent widely utilized in the management of schizophrenia and bipolar disorder. The chemical substance typically presents as a white to slightly yellow crystalline powder with a purity exceeding 98% when analyzed via High-Performance Liquid Chromatography (HPLC). Its molecular formula is C₁₇H₂₀N₄S, corresponding to a molecular weight of approximately 312.43 g/mol. This compound belongs to the thienobenzodiazepine class of drugs, distinguishing it from other antipsychotics through its unique structural configuration which facilitates broad receptor binding activity.
The primary mechanism of action involves antagonism at multiple neurotransmitter receptors, including serotonin (5-HT2A), dopamine (D2), adrenergic, histaminic, and muscarinic receptors. This multi-target profile contributes significantly to its efficacy in treating both positive symptoms like hallucinations and negative symptoms such as social withdrawal, while also helping to stabilize mood episodes in bipolar disorder. Due to its high bioavailability and ability to cross the blood-brain barrier efficiently, Olanzapine is available in various formulations, including oral tablets and intramuscular injections for acute agitation.
In the pharmaceutical industry, high-purity Olanzapine is essential for manufacturing generic medications and conducting clinical research. The "lower price" availability mentioned in market listings often refers to bulk procurement options for laboratories or manufacturers seeking cost-effective raw materials without compromising on quality standards verified by rigorous HPLC testing. While effective, the drug requires careful monitoring due to potential side effects, including metabolic changes, weight gain, and sedation. Despite these considerations, Olanzapine remains a cornerstone therapy in modern psychiatry, offering significant improvements in patient outcomes and quality of life. Its widespread adoption underscores the importance of maintaining consistent supply chains for high-quality active pharmaceutical ingredients to meet global healthcare demands effectively.